NCT04409964View on ClinicalTrials.gov

the Effect of Opioid-free General Anesthesia

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

September 1, 2021

Study Completion Date

September 20, 2021

Conditions
Gynecologic Disease
Interventions
DRUG

Dexmedetomidine Hydrochloride

dexmedetomidine iv bolus followed by the infusion of 0.1-1 ug/kg/hr during general anesthesia

DRUG

Lidocaine Hydrochloride

lidocaine iv bolus followed by the infusion of 1.5 mg/kg/hr during general anesthesia

DRUG

Remifentanil Hydrochloride

remifentanil iv infusion of 0.5-5 ng/ml (effect site concentration using TCI) during general anesthesia

Trial Locations (2)

06591

Seoul St.Mary's Hospital, Seoul

07651

Seoul St.Mary's Hospital, Seoul

All Listed Sponsors
lead

The Catholic University of Korea

OTHER

NCT04409964 - the Effect of Opioid-free General Anesthesia | Biotech Hunter | Biotech Hunter